David Zhen, MD, discussed the relevance of nivolumab in the upper gastrointestinal cancer population. In an interview with ...

A 2024 study found that in people 20 to 24 years old, GI cancer cases increased by 185% from 0.7 to 2 per 100,000 people between 1999 and 2000. For people older than 25, the increases were smaller, ...

Researchers have identified a range of genetic alterations that may lead to resistance to KRAS G12C inhibitors in patients ...

JACKSONVILLE, Fla. – A multitude of research suggests a person’s diet can affect their risk of cancer, particularly ...

RECKGIST score may predict recurrence in neurofibromatosis type 1 GISTs, potentially guiding treatment decisions, according ...

Oncolytics Biotech faces financial struggles and unclear pelareorep efficacy signals. Learn why ONCY stock's risks outweigh ...

Gleevec response in GIST varies by mutational profile, with KIT-exon-11 mutation linked to better outcomes, emphasizing ...

Marwan G. Fakih, MD, discusses the next steps for the clinical development of the balstilimab plus botensilimab in ...

Excessive alcohol consumption is a significant public health concern, responsible for approximately 6% of all deaths and contributing to 5.1% of the global disease burden. Alcohol use is a major risk ...